A shift from membranous and stromal syndecan‐1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer-Reference-Cited by-同舟云学术

A shift from membranous and stromal syndecan‐1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer

Published:2019-09-23 Issue:12 Volume:58 Page:2306-2315
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol Carcinog

Author:

Kind Simon¹,Jaretzke Annika¹,Büscheck Franziska¹,Möller Katharina¹,Dum David¹,Höflmayer Doris¹,Hinsch Andrea¹,Weidemann Sören¹,Fraune Christoph¹,Möller‐Koop Christina¹,Hube‐Magg Claudia¹,Simon Ronald¹^ORCID,Wilczak Waldemar¹,Lebok Patrick¹,Witzel Isabell²,Müller Volkmar²,Schmalfeldt Barbara²,Paluchowski Peter³,Wilke Christian⁴,Heilenkötter Uwe⁵,Leffern Ingo⁶,Krech Till⁷,Krech Rainer H.⁷,Assen Albert⁸,Bawahab Ahmed Abdulwahab⁹,Burandt Eike¹

Affiliation:

1. Institute of PathologyUniversity Medical Center Hamburg‐Eppendorf Hamburg Germany

2. Department of GynecologyUniversity Medical Center Hamburg‐Eppendorf Hamburg Germany

3. Department of GynecologyRegio Clinic Pinneberg Pinneberg Germany

4. Department of GynecologyRegio Clinic Elmshorn Elmshorn Germany

5. Department of GynecologyClinical Centre Itzehoe Itzehoe Germany

6. Department of GynecologyAlbertinen Clinic Schnelsen Hamburg Germany

7. Institute of PathologyClinical Centre Osnabrück Osnabrück Germany

8. Breast Centre OsnabrückNiels‐Stensen‐Clinic Osnabrück Germany

9. Institute of PathologyUniversity of Jeddah Jeddah Saudi Arabia

Publisher

Wiley